Rh Scientific India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-07-2024
- Paid Up Capital ₹ 0.10 M
as on 29-07-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 102.05%
(FY 2023)
- Profit 130.19%
(FY 2023)
- Ebitda 197.10%
(FY 2023)
- Net Worth 87.91%
(FY 2023)
- Total Assets 145.56%
(FY 2023)
About Rh Scientific India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rohit Gawali and Hameed Sayyad serve as directors at the Company.
- CIN/LLPIN
U85300PN2019PTC187148
- Company No.
187148
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Oct 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Rh Scientific India Private Limited offer?
Rh Scientific India Private Limited offers a wide range of products and services, including Diagnostic Imaging & Pathology Labs, Medical Test Services, Laboratory & Lab Equipment, Laboratory Chamber, Medical Laboratory Instruments, Corona Test Kit, Chemical Reagents & Catalysts, Bio Chemicals, Autoclaves, Sterilizers & Incubators, Lab Incubator.
Who are the key members and board of directors at Rh Scientific India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hameed Sayyad  | Director | 10-Oct-2019 | Current |
| Rohit Gawali | Director | 10-Oct-2019 | Current |
Financial Performance of Rh Scientific India.
Rh Scientific India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 102.05% increase. The company also saw a substantial improvement in profitability, with a 130.19% increase in profit. The company's net worth Soared by an impressive increase of 87.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rh Scientific India?
In 2023, Rh Scientific India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rh Scientific India?
Unlock and access historical data on people associated with Rh Scientific India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rh Scientific India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rh Scientific India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
